Check out the companies making headlines before the bell: Altimeter Growth (AGC) — Southeast Asia’s ride-hailing giant Grab is going public via a SPAC merger with Altimeter Growth, valued at nearly $40 billion. Grab says it intends to list on the Nasdaq under ticker symbol “GRAB” following the deal’s completion. Altimeter’s shares surged nearly 9%
admin
Delta Air Lines Inc. (DAL) is a global airline that provides transportation services for both passengers and cargo. The company’s global route network for years has served millions of customers annually, taking them to hundreds of destinations worldwide. The COVID-19 pandemic caused Delta’s passenger volume to plunge sharply in 2020. In addition to air transportation
In the Century of Biology, it pays to own the future of curing disease at the root.
Nio (NYSE:NIO) came public a few years ago with the ambition of becoming the Chinese Tesla (NASDAQ:TSLA). It will never achieve that goal, yet Nio stock is priced as though the goal is reasonable. Source: xiaorui / Shutterstock.com I explained why it can’t be Tesla last year. After a massive infusion of government capital, Nio is mainly
Amid the growth sector meltdown, shares of online real estate technology company Opendoor Technologies (NASDAQ:OPEN) have cratered. Back in early February, the OPEN stock price nearly touched $40. Today, shares trade below $20. Source: PREMIO STOCK/Shutterstock.com This selloff is a golden buying opportunity, and below $20, Opendoor stock offers long-term investors 10X upside potential. Why?
The global chip shortage does not appear to be going anywhere. And it’s interrupted some big rallies in key stocks. The question is whether the hot stocks that have cooled off present buying opportunities. In some cases, they do. After all, the chip shortage should be a relatively short-term phenomenon, even if “short-term” is measured
An artist’s rendering of a DRACO spacecraft. DARPA The Pentagon’s research and development arm on Monday awarded a trio of companies with contracts to build and demonstrate a nuclear-based propulsion system on a spacecraft in orbit by 2025. General Atomics, Lockheed Martin and Jeff Bezos’ space venture Blue Origin won the Defense Advanced Research Projects
Shoppers wearing protective masks push shopping carts inside a Costco store in San Francisco, California, on Wednesday, March 3, 2021. David Paul Morris | Bloomberg | Getty Images The pace of consumer inflation is likely to have returned to prepandemic levels in March, and it is expected to heat up even more in the next
Affirm Holdings (NASDAQ:AFRM), the buy-now, pay-later online financial technology lender that went public in January 2021, is still losing money. That said, I believe AFRM stock will keep dropping as long as Affirm keeps losing money. And this is mainly due to its huge loan losses. Source: Piotr Swat / Shutterstock.com The IPO price was
Hyliion (NYSE:HLYN) stock has had a very rough time in 201. So far, it is down 35% year-to-date as of April 9 and 21.7% in the last month alone. However, in the past year, HYLN stock has done reasonably well, up 8.2%. I believe it is poised to turn around as it is worth considerably
Coinbase (NASDAQ:COIN) is scheduled to go public on April 14 in a direct listing that will see America’s largest cryptocurrency exchange sell shares directly to investors, foregoing the traditional initial public offering (IPO) process. Source: Primakov / Shutterstock.com As I write this, a reference price has yet to be set. Nasdaq will set this price
In this article COIN Coinbase co-founder and CEO Brian Armstrong speaking at TechCrunch Disrupt SF 2018. Steve Jennings | Getty Images for TechCrunch The pending Coinbase direct listing, scheduled for April 14th on the Nasdaq under the symbol COIN, is exciting a broad base of the investment community outside the usual cryptocurrency crowd. “Coinbase is
Take a look at some of the biggest movers in the premarket: Uber (UBER) – Uber announced record gross bookings for March, with its ride-hailing business improving 9% month-over-month for its best showing in a year. The company said in a filing that demand is recovering faster than driver availability as vaccines roll out across the
Listen to Preston’s podcast about studying billionaires here: https://itunes.apple.com/us/podcast/the-investors-podcast/id928933489 Mark Cuban is a world-famous entrepreneur and investor with a net worth of $3.3 billion, according to Forbes. He is the current owner of the Dallas Mavericks, one of the teams in the Western Conference division of the National Basketball Association (NBA). He is also the
Book value and intrinsic value are two ways to measure the value of a company. There are a number of differences between them, but essentially book value is a measure of the present, while intrinsic value takes into account estimates into the future. What Is Book Value? Book value is based on the value of total assets
Kevin Matras explains the Price to Sales ratio and why it’s one of his favorite valuation metrics. Stocks highlighted include CACI, LF, NCI, RRGB and TRN.
Crypto mining stocks are the net beneficiaries of the amazing Bitcoin (CCC:BTC-USD) bull run that shows no sign of stopping. However, one that often gets lost in the shuffle is SOS (NYSE:SOS) stock. Source: Mark Agnor / Shutterstock.com The company mined its first bitcoin at the end of February, and investors are now betting big that
There’s something intriguing about companies that have stood the test of time. Many popular growth companies today won’t survive the next bear market when equity or debt capital becomes scarce. But a company like Pfizer (NYSE:PFE), which was founded in 1849, has not only survived through two World Wars but also the American Civil War.
BioNTech (NASDAQ:BNTX) stock is sitting on a 48% gain in 2021. And over the last 12 months BNTX stock is up over 168%. The reason is that the company, in partnership with Pfizer (NYSE:PFE), was the first to market with a Covid-19 vaccine. Source: Shutterstock However the significance of the vaccine is about more than
Back in 2019, Zomedica (NASDAQ:ZOM) was in enormous trouble. The company was running out of cash, and with the ZOM stock price below 50 cents, it was also running out of options. Source: Shutterstock Indeed, Zomedica closed 2018 with less than $2 million in cash. It had burned nearly $12 million that year. The Form